Efficacy and safety of recombinant urate oxidase (rasburicase) for treatment and prophylaxis of hyperuricemia in children undergoing chemotherapy

Haematologica

Volumn 90, Issue 1, 2005, Pages 141-142

  Pession, Andrea ^a,f   Barbieri, Eveline ^a   Santoro, Nicola ^b   Paolucci, Paolo ^c   Porta, Fulvio ^d   Locatelli, Franco ^e  

^a Clinica Pediatrica   (Italy)

^b POLICLINICO   (Italy)

^c Oncoematologia Pediatrica   (Italy)

^d Clinica Pediatrica   (Italy)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CREATININE; RASBURICASE; URIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HUMAN; HYPERURICEMIA; INFANT; KIDNEY FUNCTION; MALE; NEPHROBLASTOMA; NONHODGKIN LYMPHOMA; RETROSPECTIVE STUDY; SOLID TUMOR; TUMOR LYSIS SYNDROME;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERURICEMIA; INFANT; INFANT, NEWBORN; MALE; RECOMBINANT PROTEINS; TUMOR LYSIS SYNDROME; URATE OXIDASE;

EID: 13244268623     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Wossmann W, Schrappe M, Meyer U, Zimmermann M, Reiter A. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase. Ann Hematol 2003;82:160-5.
2. Pui CH, Mahmoud HH, Wiley JM, Woods GM, Leverger G, Camitta B, et al. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol 2001;19:697-704.
3. Patte C, Sakiroglu C, Ansoborlo S, Baruchel A, Plouvier E, Pacquement H, Babin-Boilletot A for the Societè Francaise d'Oncologie Pediatrique. Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Societe Francaise d'Oncologie Pediatrique LMB89 protocol. Ann Oncol 2002;13:789-95:
4. Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL, et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 2001;1997:2998-3003.
5. Bayol A, Capdevielle J, Malazzi P, Buzy A, Claude Bonnet M, Colloc'h N, Momon JP, Loyaux D, Ferrara P. Modification of a reactive cysteine explains differences between rasburicase and Uricozyme, a natural Aspergillus flavus uricase. Biotechnol Appl Biochem 2002;36(Pt 1):21-31.
6. th annual European Conference. Cannes. Proc Value in Health 2001;4.